Month: January 2013

Actavis, Inc. ( ACT ), formerly known as Watson Pharmaceuticals, Inc., recently provided an update on its 2012 performance, 2013 outlook and prospects. […]

Repros Therapeutics Inc. ( RPRX ) recently announced that results from the first pivotal study (ZA-301) of Androxal will be declared in the third quarter of 2013 instead of the second quarter. The candidate is being evaluated for the treatment of secondary hypogonadism. […]

On Jan 30, 2013, we downgraded Molina Healthcare Inc. ( MOH ) to Neutral from Outperform based on its rising medical costs and the negative impact of the healthcare reforms. […]

Pluristem Therapeutics, Inc. ( PSTI ) recently announced that it has taken possession of its new state-of-the-art facility after initiating the validation process earlier in Jan 2013. Pluristem is currently shifting its manufacturing process to this facility. […]

On Jan 28, we downgraded specialty departmental store Kohl’s Corporation ( KSS ) to Underperform due to weaker-than-expected holiday season sales, which also forced the company to reduce its earnings expectation for the fourth quarter and fiscal year 2012. Why the Downgrade? Kohl’s performance during the holiday season was impacted by unfavorable weather conditions and lower consumer confidence, which forced Kohl’s to give more than expected discounts to its customers. […]

NASDAQ OMX Group Inc. ’s ( NDAQ ) fourth-quarter 2012 operating earnings per share of 64 cents modestly surpassed the Zacks Consensus Estimate of 61 cents as well as the prior-year quarter earnings of 62 cents. NASDAQ’s GAAP net income was $85 million or 50 cents per share, fairly higher than $82 million or 45 cents per share recorded in the year-ago quarter […]

Electricity and natural gas company Xcel Energy Inc. ( XEL ) posted operating earnings for the fourth quarter 2012 of 29 cents per share, in line with the year-ago figure. […]

JA Solar Holdings Co. Ltd. ( JASO ) has completed the supply of 9.5 megawatt (“MW”) of PV modules for Volkswagen Solar Park, located in the vicinity of the Volkswagen manufacturing plant at Chattanooga, Tennessee. […]

ConAgra Foods Inc. ( CAG ), a leading food company, successfully acquired Ralcorp Holdings Inc., a branded food company for approximately $6.8 billion, including debt or $90.00 per share in cash. The acquisition, agreed upon on Nov 26, 2012, received regulatory approvals and Ralcorp shareholders’ sanction and came to a close on Jan 29, 2013 […]

MasterCard Inc. ’s ( MA ) fourth-quarter 2012 operating earnings per share of $4.86 modestly beat the Zacks Consensus Estimate of $4.79 and the year-ago quarter’s earnings of $4.03, primarily based on low share count. Net income for the reported quarter stood at $605 million, up 17.7% from $514 million in the prior-year quarter […]

Ryder System Inc. ( R ), one of the world's largest providers of integrated logistics and transportation solutions, reported stellar fourth quarter and full-year 2012 results. The outperformance was backed by strong contributions from all business units along with greater number of used vehicle sales plus lower selling and administrative expenses. […]

Occidental Petroleum Corporation 's ( OXY ) fourth-quarter 2012 pro forma earnings were $1.83, beating the Zacks Consensus Estimate of $1.66. Quarterly earnings were lower than the prior-year earnings of $2.02 per share. Including a charge of $1.41 per share related to the impairment of gas assets in the Midcontinent, GAAP earnings per share were 42 cents, down from $2.01 in the year-ago quarter. […]

U.S. health insurer Aetna Inc. ( AET ) reported its fourth quarter 2012 earnings of 94 cents per share a couple of pennies shy of the Zacks Consensus Estimate of 96 cents per share […]

Time Warner Cable Inc. ( TWC ) reported fourth-quarter 2012 financial results, where the bottom line beat the Zacks Consensus Estimate while the top line missed the same. Quarterly adjusted (excluding special items) earnings per share of $1.57 beat the Zacks Consensus Estimate of $1.56 […]